ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST

ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST

Atrial fibrillation (AF) is one of the most pertinent problems in internal medicine, primarily due to its severe thrombotic complications, such as stroke, myocardial infarction, pulmonary artery and thromboembolism, and their medical and economic consequences. This emphasises the importance of the d...

Full description

Bibliographic Details
Main Authors: A. L. Vertkin, E. A. Algiyan
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2014-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
atrial fibrillation
coronary heart disease
stroke
antithrombotic therapy
new oral anticoagulants
thrombosis risk factors
rivaroxaban
Online Access:https://cardiovascular.elpub.ru/jour/article/view/13
id doaj-9325473fd4ee44b1bd48ae3587956afb
record_format Article
spelling doaj-9325473fd4ee44b1bd48ae3587956afb2021-07-28T13:50:57Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252014-02-01131698110.15829/1728-8800-2014-1-69-8113ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALISTA. L. Vertkin0E. A. Algiyan1A. I. Evdokimov Moscow State Medico-Stomatological University, MoscowA. I. Evdokimov Moscow State Medico-Stomatological University, MoscowAtrial fibrillation (AF) is one of the most pertinent problems in internal medicine, primarily due to its severe thrombotic complications, such as stroke, myocardial infarction, pulmonary artery and thromboembolism, and their medical and economic consequences. This emphasises the importance of the detection of risk factors relevant to prognosis and of the effective and safe long-term preventive treatment with anticoagulants, particularly for ambulatory patients. At the moment, the focus is on the so-called new oral anticoagulants which demonstrate a range of benefits, compared to indirect anticoagulants.https://cardiovascular.elpub.ru/jour/article/view/13atrial fibrillationcoronary heart diseasestrokeantithrombotic therapynew oral anticoagulantsthrombosis risk factorsrivaroxaban
collection DOAJ
language Russian
format Article
sources DOAJ
author A. L. Vertkin
E. A. Algiyan
spellingShingle A. L. Vertkin
E. A. Algiyan
ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST
Кардиоваскулярная терапия и профилактика
atrial fibrillation
coronary heart disease
stroke
antithrombotic therapy
new oral anticoagulants
thrombosis risk factors
rivaroxaban
author_facet A. L. Vertkin
E. A. Algiyan
author_sort A. L. Vertkin
title ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST
title_short ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST
title_full ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST
title_fullStr ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST
title_full_unstemmed ATRIAL FIBRILLATION PATIENTS AT THE AMBULATORY VISIT TO THE INTERNAL MEDICINE SPECIALIST
title_sort atrial fibrillation patients at the ambulatory visit to the internal medicine specialist
publisher «SILICEA-POLIGRAF» LLC
series Кардиоваскулярная терапия и профилактика
issn 1728-8800
2619-0125
publishDate 2014-02-01
description Atrial fibrillation (AF) is one of the most pertinent problems in internal medicine, primarily due to its severe thrombotic complications, such as stroke, myocardial infarction, pulmonary artery and thromboembolism, and their medical and economic consequences. This emphasises the importance of the detection of risk factors relevant to prognosis and of the effective and safe long-term preventive treatment with anticoagulants, particularly for ambulatory patients. At the moment, the focus is on the so-called new oral anticoagulants which demonstrate a range of benefits, compared to indirect anticoagulants.
topic atrial fibrillation
coronary heart disease
stroke
antithrombotic therapy
new oral anticoagulants
thrombosis risk factors
rivaroxaban
url https://cardiovascular.elpub.ru/jour/article/view/13
work_keys_str_mv AT alvertkin atrialfibrillationpatientsattheambulatoryvisittotheinternalmedicinespecialist
AT eaalgiyan atrialfibrillationpatientsattheambulatoryvisittotheinternalmedicinespecialist
_version_ 1721271026070847488

Similar Items